Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

Dermatologists performed the most outpatient cosmetic procedures in the U.S. from 1995 to 2003, especially on white women aged 40 to 59.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

FUE effectively corrects poorly designed hairlines in men with androgenetic alopecia.

MIR135b affects wound healing by targeting genes, and PDRN may help heal wounds by altering this pathway.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

MsPG3 protein gathers at root hair tips, aiding growth.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

The package offers tools for exploring potential miRNA changes in female hair loss.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The study provides exploratory findings on miRNA changes in female hair loss.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Mitochondrial genes help predict breast cancer outcomes and spread.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

The study explores miRNA changes in female hair loss.

The study explores miRNA changes in female hair loss.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.